Results 91 to 100 of about 29,657 (272)

Analysis of antibiotic resistance genes in multidrug-resistant acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center [PDF]

, 2006
Military medical facilities treating patients injured in Iraq and Afghanistan have identified a large number of multidrug-resistant (MDR) Acinetobacter baumannii isolates.
Adams, Jennifer M., Bajaksouzian, Saralee, Bonomo, Robert A., Craft, David W., Donskey, Curtis J., Ecker, David J., Eshoo, Mark W., Ewell, Allesa J., Fishbai, Joel T., Hujer, Andrea M., Hujer, Kristine M., Hulten, Edward A., Jacobs, Michael R., Massire, Christian, Paterson, David L., Rather, Philip N., Sampath, Rangarajan, Thomson, Jodi M.   +17 more
core   +3 more sources

An Investigation of Colistin Heteroresistance in Klebsiella pneumoniae Isolates in Iran

BioMed Research International, Volume 2026, Issue 1, 2026.
Background According to the World Health Organization 2024 bacterial priority pathogens list, carbapenem‐resistant Enterobacterales (CRE) were listed among the critical priority pathogens. Heteroresistance (i.e., a bacterial isolate that appears susceptible but harbors resistant subpopulations) represents a challenge in traditional laboratory testing ...
Zohreh Riahi Rad, Zahra Riahi Rad, Hossein Goudarzi, Mehdi Goudarzi, Mohsen Javidi, Javad Yasbolaghi Sharahi, Masoud Kargar, Ali Hashemi, Baisakhi Banerjee   +8 more
wiley   +1 more source

Molecular epidemiology of Acinetobacter baumannii during COVID-19 at a hospital in northern China

Annals of Clinical Microbiology and Antimicrobials
Background The wide spread of carbapenem-resistance clones of Acinetobacter baumannii has made it a global public problem. Some studies have shown that the prevalence of Acinetobacter baumannii clones can change over time.
Xinlin Huang, Nianzhi Ning, Deyu Li, Suming Chen, Liangyan Zhang, Huan Wang, Chunmei Bao, Xiaolan Yang, Boan Li, Hui Wang   +9 more
doaj   +1 more source

Antibacterial Therapy Options for Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

Антибиотики и Химиотерапия
The review presents current treatment regimens for infections associated with carbapenem-resistant Acinetobacter baumannii, which are leading nosocomial pathogens exhibiting multidrug resistance to available antibacterial drugs. To date, widely used beta-
A. R. Goncharova, V. V. Gostev, N. E. Goncharov, O. S. Kalinogorskaya, N. S. Gladyshev   +4 more
doaj   +1 more source

A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing acinetobacter pittii sequence type 119 in Australia [PDF]

, 2015
An IMP-4-producing Acinetobacter pittii strain coproducing oxacillinases was isolated from a leg wound of a 67-year-old female patient. Identification to the species level by rpoB and gyrB sequencing and multiplex-PCR-based analysis revealed that the ...
Derrington, Petra, Kamolvit, Witchuda, Paterson, David L., Sidjabat, Hanna E.   +3 more
core   +1 more source

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia [PDF]

Clinical Microbiology and Infection, 2008
Carbapenem-resistant Acinetobacter baumannii (CR-Ab) ranked third, with a frequency of 24.8%, among 202 strains of multidrug-resistant bacteria isolated from clinical samples in the main hospital of New Caledonia in 2004. All CR-Ab isolates were analysed by isoelectric focusing, conjugation, pulsed-field gel electrophoresis and PCR for the presence of ...
Le Hello, S., Falcot, V, Lacassin, F, Baumann, F, Nordmann, P, Naas, T   +5 more
openaire   +2 more sources

Biofilm Formation in Clinical Acinetobacter baumannii Is Influenced by Isolate Source and Is Inversely Correlated With Antibiotic Resistance

BioMed Research International, Volume 2026, Issue 1, 2026.
Acinetobacter baumannii is a troublesome bacterium that is highly prevalent in hospital settings, particularly in intensive care units (ICUs). Biofilm is one of the main virulence factors that makes A. baumannii a successful pathogen, enabling it to survive the harshest environments.
Qutaiba Ababneh, Dua’a Alawneh, Ziad Jaradat, Esra’a Al-Zoubi, Ali Atoom, Neda’a Aldaken, Ekhlas Al-Rousan, Yazeed Alshari, Ismail Saadoun, Baisakhi Banerjee   +9 more
wiley   +1 more source

Detection of Insertion Sequence ISAba1 Among Clinical Isolates of Carbapenems-Resistant Acinetobacter baumannii

Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2014
Acinetobacter baumannii is an opportunistic pathogen with increasing clinical importance, especially in immunocompromised patients, causing nosocomial infections of the lungs, urinary tract and surgical wounds.
Saad Laiby Hamed
doaj   +1 more source

First Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn2006 in Spain [PDF]

, 2013
A carbapenem-resistant Acinetobacter baumannii clinical isolate belonging to European clone II and sequence type 2 was recov-ered from a patient in the Son Espases hospital in Mallorca, Spain.
Bou, G, Espinal, P, Fernández-Cuenca, F, Gato, E, Macià, M D, Oliver, A, Roca, I, Rodríguez-Baño, J, Ruíz, E, Tomás, M, Vila, J   +10 more
core   +1 more source

Mortality in Ventilator‐Associated Tracheobronchitis and Pneumonia in Oncology Patients: The Impact of Microbiological Aspects

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background Most evidence on ventilator‐associated pneumonia (VAP)–related and ventilator‐associated tracheobronchitis (VAT)–related mortality comes from general ICU settings, with limited data on critically ill cancer patients. This study aimed to characterize the microbiological profile and resistance patterns in an oncology hospital and evaluate ...
Vitor Falcao de Oliveira, Débora de Oliveira Lopes, Valdirene Santos Folli Cabral, Luiz Dalfior Junior, Simone Siqueira Matos, Luciana Alexandra Antônia de Almeida, Larissa Vasconcelos Barreto, João Manoel da Silva Junior, Ana Paula Cury, Odeli Nicole Encinas Sejas, Adriana Satie Gonçalves Kono Magri, Edson Abdala, Arif Ansori   +12 more
wiley   +1 more source